The Indian pharma market witnessed a growth of 37.2 percent in value terms for Q1FY22, partly aided by the COVID-19 portfolio. Meanwhile, these ...
Read more: Pharma sector Q1FY22 preview: Strong growth seen in India biz; US sales likely to remain flat